Programmable Cond-siRNA for Conditional Gene Silencing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current RNAi therapy faces challenges in delivering RNAi agents specifically to disease-related cells due to poorly suppressed background drug activity, weak ON state drug potency, input and output sequence overlap, and short device lifetimes, limiting the effectiveness of conditionally activated oligonucleotide therapeutics in mammalian cells.

Innovation Solution

Development of a programmable, conditionally activated small interfering RNA (Cond-siRNA) construct comprising a sensor strand, a core strand, and a guide strand, which forms a single structure via complementary binding, allowing for specific activation by cellular RNA transcripts and improved stability and potency through chemical modifications such as LNA and 2'-O-methyl modifications.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If strand displacement switches are used to create conditionally activated RNAi agents, then conditional activation capability is achieved, but background drug activity is poorly suppressed

Engineering Contradiction:
Improveconditional activation capabilityVSAvoidbackground drug activity suppression
Core Design Contradiction:
Adaptability or versatilityVSReliability

Solution Approach 1:

The RNAi agent is divided into three separate strands: a guide strand, a core strand, and a sensor strand. The guide strand and core strand form an inactive RNAi duplex that is segmented from the active state by the sensor strand's blocking sequence. This segmentation allows the drug to remain inactive until the sensor strand is displaced by the target RNA, thereby suppressing background activity while maintaining conditional activation capability.

Inventive Principle:
Principle #1Segmentation

2Adaptability or versatility

If strand displacement switches are used for conditional activation, then programmability is achieved, but ON state drug potency is weak

Engineering Contradiction:
ImproveprogrammabilityVSAvoidON state drug potency
Core Design Contradiction:
Adaptability or versatilityVSPower

Solution Approach 1:

The guide strand and core strand are pre-assembled into an RNAi duplex structure that is primed and ready for activity. The sensor strand is pre-positioned to block this structure. When the sensor strand is displaced by the target RNA, the pre-formed RNAi duplex is immediately activated without requiring additional assembly steps, thereby achieving strong ON state potency while maintaining programmability through the sensor strand sequence.

Inventive Principle:
Principle #10Preliminary action

3Device complexity

If sensor duplex and RNAi duplex are attached via core strand, then single construct simplicity is achieved, but input and output sequence overlap occurs

Engineering Contradiction:
Improveconstruct simplicityVSAvoidsequence overlap
Core Design Contradiction:
Device complexityVSLoss of information

Solution Approach 1:

The core strand is designed with differentiated regions: a first region that binds to the sensor strand to form the sensor duplex, and a second region that binds to the guide strand to form the RNAi duplex. This local differentiation ensures that the sequences in these regions are distinct and do not overlap with the input or output sequences, thereby preventing sequence overlap while maintaining the simplicity of a single construct design.

Inventive Principle:
Principle #3Local quality

4Reliability

If conventional RNAi agents are used, then gene silencing capability is achieved, but device lifetime is short

Engineering Contradiction:
Improvegene silencing capabilityVSAvoiddevice lifetime
Core Design Contradiction:
ReliabilityVSDuration of action of stationary object

Solution Approach 1:

The RNAi agent incorporates chemically modified nucleotides including 2'-O-methyl modifications and locked nucleic acid (LNA) modifications. These composite chemical structures enhance the stability and nuclease resistance of the RNA strands, thereby extending the device lifetime in biological environments while preserving the gene silencing capability through maintained structural integrity and function.

Inventive Principle:
Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The Cond-siRNA achieves significant silencing of target genes with over 90% efficiency in cells expressing sequence-matched RNA transcripts while strongly suppressing background RNAi activity in mismatched inputs, maintaining integrity over days in mammalian cytosol and enabling precise gene expression control.

Implementation Method 1

the sensor strand and the core strand bind complementarily to form a sensor duplex

Methodology Applied
Scientific EffectComplementary base pairing: Chemical Bonding

Implementation Method 2

the guide strand and the core strand bind complementarily to form a RNAi duplex

Methodology Applied
Scientific EffectComplementary base pairing: Chemical Bonding

Implementation Method 3

programmable, conditionally activated small interfering RNA (Cond-siRNA) construct

Methodology Applied
Scientific EffectRNA interference: Enzyme

Data Source

PatentUS20240401043A1Programmable conditional sirnas and uses thereof
Publication Date: 2024.12.05 CALIFORNIA INST OF TECH
  • US20240401043A1 patent drawing
  • US20240401043A1 patent drawing
  • US20240401043A1 patent drawing

AI summary

Disclosed herein are programmable, conditionally activated small interfering RNA constructs (Cond-siRNAs) and methods of making and using the same as therapeutic agents. The Cond-siRNA comprises a sensor strand, a core strand, and a guide strand, which crossover to form a sensor duplex and a RNAi duplex attached to each other to form a single structure. Upon binding an input strand to the sensor strand, the Cond-siRNA is activated and releases RNAi targeting a desired gene.